Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYSLTR1 | Q9Y271 | 5/20 | 1.00 |
| ▸ | ABCC1 | P33527 | 4/20 | 1.00 |
| ▸ | ABCC2 | Q92887 | 3/20 | 1.00 |
| ▸ | MEN1 | O00255 | 1/20 | 1.00 |
| ▸ | ABCC3 | O15438 | 1/20 | 1.00 |
| ▸ | ABCC4 | O15439 | 1/20 | 1.00 |
| ▸ | ABCC5 | O15440 | 1/20 | 1.00 |
| ▸ | SLCO2B1 | O94956 | 1/20 | 1.00 |
| ▸ | ABCB11 | O95342 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 1/20 | 1.00 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 1.00 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 1.00 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 1.00 |
| ▸ | CYSLTR2 | Q9NS75 | 3/20 | 0.86 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Verlukast SCHEMBL37246 | 1.00 | CYSLTR1 (1.00) | CYSLTR1ABCC1ABCC2MEN1ABCC3 | |
| Mk-571 SCHEMBL30509651 | 1.00 | CYSLTR1 (1.00) | CYSLTR1ABCC1ABCC2MEN1ABCC3 | |
| Mk-571 SCHEMBL9231584 | 1.00 | CYSLTR1 (1.00) | CYSLTR1ABCC1ABCC2MEN1ABCC3 | |
| Verlukast SCHEMBL2729252 | 1.00 | CYSLTR1 (1.00) | CYSLTR1ABCC1ABCC2MEN1ABCC3 | |
| Mk-571 SCHEMBL156452 | 0.99 | CYSLTR1 (0.98) | CYSLTR1ABCC1ABCC2MEN1ABCC3 | |
| Verlukast SCHEMBL156454 | 0.99 | CYSLTR1 (0.98) | CYSLTR1ABCC1ABCC2MEN1ABCC3 | |
| Dimethylcarbate SCHEMBL9327878 | 0.95 | CYSLTR1 (0.90) | CYSLTR1ABCC1ABCC2MEN1ABCC3 | |
| SCHEMBL17833480 | 0.94 | CYSLTR1 (0.89) | CYSLTR1ABCC1ABCC2MEN1ABCC3 | |
| SCHEMBL9267947 | 0.93 | CYSLTR1 (1.00) | CYSLTR1ABCC1ABCC2MEN1ABCC3 | |
| SCHEMBL9265732 | 0.93 | CYSLTR1 (1.00) | CYSLTR1ABCC1ABCC2MEN1ABCC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2617 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250009940-A1 | ANTIMICROBIAL WRAPS FOR MEDICAL IMPLANTS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2025-01-09 | — | — | US | claimed |
| EP-4433107-A1 | ANTIMICROBIAL WRAPS FOR MEDICAL IMPLANTS | Board of Regents, The University of Texas System (US) | 2024-09-25 | — | — | EP | claimed |
| US-20230414575-A1 | MK2 ACTIVATING COMPOUNDS FOR USE IN TREATING VASCULAR LEAK AND ENDOTHELIAL BARRIER DISORDERS | AKTTYVA THERAPEUTICS INC (US) | 2023-12-28 | — | — | US | claimed |
| EP-4244341-A2 | MK2 ACTIVATING COMPOUNDS FOR USE IN TREATING VASCULAR LEAK AND ENDOTHELIAL BARRIER DISORDERS | Akttyva Therapeutics, Inc. (US) | 2023-09-20 | — | — | EP | claimed |
| WO-2023091998-A1 | ANTIMICROBIAL WRAPS FOR MEDICAL IMPLANTS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2023-05-25 | — | — | WO | claimed |
| WO-2023075715-A1 | A PHARMACEUTICAL FORMULATION INCLUDING LEUKOTRIENE RECEPTOR ANTAGONISTS AND/OR LEUKOTRIENE SYNTHESIS INHIBITORS COMBINED WITH NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) | VSY BIYOTEKNOLOJI VE ILAC SANAYI ANONIM SIRKETI (TR) | 2023-05-04 | — | — | WO | claimed |
| WO-2023069028-A1 | A PROCESS FOR THE PREPARATION OF DRY POWDER COMPOSITIONS FOR INHALATION | Arven Ilac Sanayi Ve Ticaret Anonim Sirketi (TR) | 2023-04-27 | — | — | WO | claimed |
| WO-2022175402-A1 | QUINUCLIDINE-3-ONE DERIVATIVES | APREA THERAPEUTICS AB (SE) | 2022-08-25 | — | — | WO | claimed |
| EP-1931320-B1 | MICROPARTICLES WITH MODIFIED RELEASE OF AT LEAST ONE ACTIVE PRINCIPLE AND ORAL DOSAGE FORM COMPRISING THE SAME | FLAMEL IRELAND LTD (IE) | 2022-06-15 | — | — | EP | claimed |
| WO-2022104097-A2 | MK2 ACTIVATING COMPOUNDS FOR USE IN TREATING VASCULAR LEAK AND ENDOTHELIAL BARRIER DISORDERS | AKTTYVA THERAPEUTICS, INC. (US) | 2022-05-19 | — | — | WO | claimed |
| WO-2002060898-A1 | THIAZOLYL-, OXAZOLYL-, PYRROLYL-, AND IMIDAZOLYL-ACID AMIDE DERIVATIVES USEFUL AS INHIBITORS OF PDE4 ISOZYMES | PFIZER PRODUCTS INC. (US) | 2002-08-08 | — | — | WO | claimed |
| EP-1229034-A1 | Nicotinamide derivatives and their mimetics as inhibitors of PDE4 isozymes | Pfizer Products Inc. (US) | 2002-08-07 | — | — | EP | claimed |
| WO-2002051814-A1 | BENZOYLPYRIDAZINES | MERCK PATENT GMBH (DE) | 2002-07-04 | — | — | WO | claimed |
| JP-2002505275-A | — | — | 2002-02-19 | — | — | JP | claimed |
| WO-2001057036-A1 | NICOTINAMIDE BENZOFUSED-HETEROCYCLYL DERIVATIVES USEFUL AS SELECTIVE INHIBITORS OF PDE4 ISOZYMES | PFIZER PRODUCTS INC. (US) | 2001-08-09 | — | — | WO | claimed |
| WO-2001057025-A1 | PYRIMIDINE CARBOXAMIDES USEFUL AS INHIBITORS OF PDE4 ISOZYMES | PFIZER PRODUCTS INC. (US) | 2001-08-09 | — | — | WO | claimed |
| EP-1083921-A1 | NOVEL LEUKOTRIENE RECEPTOR ANTAGONISTS AND THEIR USES | Advanced Medicine, Inc. (US) | 2001-03-21 | — | — | EP | claimed |
| EP-1059917-A1 | ANTI-ASTHMA THERAPY | ALZA CORPORATION (US) | 2000-12-20 | — | — | EP | claimed |
| WO-1999064052-A1 | NOVEL LEUKOTRIENE RECEPTOR ANTAGONISTS AND THEIR USES | ADVANCED MEDICINE, INC. (US) | 1999-12-16 | — | — | WO | claimed |
| WO-1999044592-A1 | ANTI-ASTHMA THERAPY | ALZA CORPORATION (US) | 1999-09-10 | — | — | WO | claimed |